| __timestamp | Biogen Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 12122000 |
| Thursday, January 1, 2015 | 2012800000 | 13380000 |
| Friday, January 1, 2016 | 1973300000 | 21221000 |
| Sunday, January 1, 2017 | 2253600000 | 26887000 |
| Monday, January 1, 2018 | 2597200000 | 27863000 |
| Tuesday, January 1, 2019 | 2280600000 | 55908000 |
| Wednesday, January 1, 2020 | 3990900000 | 59392000 |
| Friday, January 1, 2021 | 2501200000 | 69012000 |
| Saturday, January 1, 2022 | 2231100000 | 36082000 |
| Sunday, January 1, 2023 | 2702600000 | 24537000 |
| Monday, January 1, 2024 | 2041800000 |
Unlocking the unknown
In the competitive landscape of biotechnology, innovation is the lifeblood of progress. Over the past decade, Biogen Inc. and Ligand Pharmaceuticals Incorporated have demonstrated contrasting approaches to research and development (R&D) investments. Biogen, a leader in neurological therapies, has consistently outpaced Ligand, investing nearly 70 times more in R&D annually. From 2014 to 2023, Biogen's R&D expenses surged by approximately 43%, peaking in 2020 with a remarkable $3.99 billion. In contrast, Ligand's investment, while growing, reached its zenith in 2021 with $69 million, a modest figure compared to Biogen. This disparity highlights Biogen's aggressive pursuit of innovation, crucial for breakthroughs in complex neurological disorders. As the biotech industry evolves, these investment strategies will shape the future of medical advancements, underscoring the importance of sustained R&D funding in driving transformative healthcare solutions.
Sanofi vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Biogen Inc. or Genmab A/S: Who Invests More in Innovation?
Comparing Innovation Spending: Biogen Inc. and Incyte Corporation
R&D Spending Showdown: Genmab A/S vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds